Til Therapy News Today

Daniel Olson, MD, discusses the significance of the FDA approval of lifileucel for patients with advanced melanoma.

Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.

Cytiva addresses challenges at each stage of the TIL (Tumor-infiltrating lymphocyte) therapy manufacturing workflow.

Iovance Biotherapeutics has submitted a rolling biologics license application to the FDA seeking the approval of the tumor infiltrating lymphocyte therapy lifileucel for the treatment of patients with advanced unresectable or metastatic melanoma who progressed on or after prior anti–PD-1/L1 therapy and targeted therapy.

7% in the other group. fda approval for t.i.l. therapy could come next year. researchers at the moffitt cancer center believe that could be just the beginning. >> t.i.l. therapy will be a game changer for many cancers. >> reporter: its already been a game changer for holly. >> life is exciting. god gave me an opportunity to do it again. >> reporter: stephanie gosk, nbc news. up next, as we continue tonight, royal revelations. what will prince harry and meghan markle say at a new docuserieies c...